... aimed to compare the effects of pitavastatin and standard therapy on mortality and cardiovascular events in chronic hemodialysis patients with dyslipidemia in Japan. Methods: Patients on chronic hemodialysis with dyslipidemia were randomized into pitavastatin-administered (pitavastatin group) or dietary...

...Tetsuo Shoji Background: Dyslipidemia is a common metabolic complication in patients with chronic kidney disease and is detected as changes in lipoprotein concentrations in serum. Summary: Recently, other features of lipid abnormalities have been described, such as alterations in serum n-3...

...Elaine Ku; Vito Campese Patients with chronic kidney disease (CKD) suffer from high rates of cardiovascular morbidity and mortality. The general approach to traditional cardiovascular risk factor modification via dyslipidemia control has not been thoroughly tested in patients with all stages of CKD...

... factors in the post-transplant period that further accentuate the prevalence and severity of several CVD risk factors. It is well recognized that immunosuppressive agents have associated effects on hypertension, dyslipidemia, and diabetes [ 3 ]. Aggressive management of these factors must be carried out...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. AGEs Diabetes Uremia Middle molecules Dyslipidemia LDL Blood Puril l 995; 13:160-170 Richard Bucala Helen Vlassara The Picower Institute...

...Robert.D. Toto Dyslipidemia in end-stage renal disease is a common problem and may contribute to the high rates of morbidity and mortality in this population. Recent studies indicate that defective lipolysis is a major factor in the development of this disorder which is characterized by increased...

..., instructions or products referred to in the content or advertisements. Chronic kidney disease Dyslipidemia Body mass index Hyperglycemia Glucose exposure Original Paper Blood Purif 2008;26:423 428 DOI: 10.1159/000153248 Received: March 28, 2008 Accepted: June 26, 2008 Published online: September 6...

...Christoph Wanner; Vera Krane Uremic patients suffer from a secondary form of complex dyslipidemia consisting of quantitative and qualitative abnormalities in serum lipoproteins resulting in altered lipoprotein composition and metabolism. The most prominent are an increase in serum triglyceride...

... is associated with an improvement in the lipid profile in patients with secondary hyperparathyroidism. However, it remains to be established whether ameliorating the uremic dyslipidemia results in any long-term clinical benefits. 12 2 1998 1998 Copyright / Drug Dosage / Disclaimer Copyright: All...